ipmetrix

Seminar on TRIZ for IP Generation

ipMetrix Consulting Group is organising a Seminar on TRIZ for IP Generation, Venue: Kensington Hall, Vivanta By Taj,  Bangalore on 1st August, 2014. Registration fee:  INR 10,000/- Plus taxes. Click here to Register TRIZ is a premier disruptive technology for innovation that can be used throughout many industries and sciences. TRIZ is systematic processes that develops critical thinking skills and promote

Seminar on TRIZ for IP Generation Read More »

Book on IPR

K Rosaiah, Governor launched a book on Intellectual Property Rights (IPR) by noted IPR expert Swapna Sundar, at an event recently. The book works on a comprehensive and practical discussion of the role of IP in the techno-commercial space and draws from the rich experience of companies like Hyundai and Google to elucidate strategies that

Book on IPR Read More »

Acquisitions

Patent Freedom acquired by RPX Corporation  PatentFreedom, the first provider of data, intelligence, and consulting on non-practicing entities (NPEs) is acquired by RPX Corporation the leading provider of patent risk management. According to the sources, current subscribers to PatentFreedom will continue to have full access to its database of NPE litigations and profiles.  However, RPX

Acquisitions Read More »

New Patent Prosecution Highway between the UK and China

A new pilot Patent Prosecution Highway (PPH) programme has been launched between the UK Intellectual Property Office (IPO) and the State Intellectual Property Office (SIPO) of the People’s Republic of China. The UK-China PPH pilot started on the 1 July 2014 and will run for an initial period of two years, ending on 30 June

New Patent Prosecution Highway between the UK and China Read More »

Another Hepatitis C Drug to come in the Market Soon

Hepatitis C has become one of the hottest categories in drug research as companies race to develop a combination therapy without injections and debilitating side effects. Some have had their promising candidates fail after extensive testing, due to dangerous side effects, but Gilead Sciences Inc is already raking in billions of dollars from its ground

Another Hepatitis C Drug to come in the Market Soon Read More »